Synribo is a medication that is used to treat a type of blood cancer called chronic myeloid leukemia (CML). It belongs to a class of drugs known as tyrosine kinase inhibitors, which work by blocking the action of an abnormal protein that causes cancer cells to grow and multiply.
This medication is typically prescribed for patients who have not responded well to other treatments or who have developed resistance to other medications. It is taken orally, usually once or twice a day, as directed by your healthcare provider.
As with any medication, there are potential side effects associated with Synribo. These can include nausea, vomiting, diarrhea, fatigue, and low blood cell counts. It is important to discuss any concerns or side effects with your healthcare provider, as they may be able to provide guidance on managing these symptoms.
It is also important to follow your healthcare provider’s instructions carefully when taking Synribo. This may include regular blood tests to monitor your response to the medication and adjust your dosage as needed.
Overall, Synribo can be an effective treatment option for patients with CML who have not had success with other medications. By working closely with your healthcare provider and following their guidance, you can help manage your condition and improve your quality of life.
EN 
ES 
FR 
PT 
ZH